bta takeover very possible, page-26

Jessie

Re ''as quoted by Wilson HTM "A possible explanation is
that the expected volumes were shipped but unit pricing was discounted materially."


I called BTA and they categorically say that GSK did not approach them to discount Relenza. They also think it is highly unlikely GSK heavily discounted relenza.

BTA gave permission for the WHO donation and believe they must be consulted for GSK to do this.

Wilsons HTM have gone off on a limb here. They are one of the only reporting analysts who do not talk with the company.

So this is just an excuse by Wilsons to make there own 'balls up' research look better.